Vanderbilt Health News Archive — Page 186 of 390

Portrait of a man in a dark suit and striped tie against a black background.
January 24, 2017

Richard Kogan, psychiatrist and concert pianist, is Leonard Visiting Scholar, Feb. 8 and 9

His piano performances have been reviewed by The New York Times, which praised his “exquisite playing,” and by The Boston Globe, which wrote, “Kogan has somehow managed to excel at the world’s two most demanding professions.”

By Vanderbilt Health News
Several vaccine vials labeled “Vaccine For Health Protection” arranged with a syringe on a white background.
January 20, 2017

Improving vaccine formulations

The compound MPLA is an attractive vaccine component, designed to elicit a robust immune response.

By Sanjay Mishra
Professional headshot of a smiling woman with shoulder-length brown hair wearing a black blazer.
January 19, 2017

VICC joins cancer genomic data sharing initiative

Vanderbilt-Ingram Cancer Center (VICC) has joined an international consortium of leading cancer centers to share genomic data from patients in an effort to accelerate the pace of cancer research and improve precision medicine.

By Vanderbilt Health News
Infographic titled “EpicLeap by the Numbers” showing metrics including 60,000 end-user devices, 24,000 end users, 1,200 testing scripts, 1,200 oncology protocols, 800 ambassadors, 500 workflows, 14,000 build tasks, and other implementation statistics.
January 19, 2017

Newly available infographic shows vast scope of EpicLeap program

“EpicLeap by the Numbers” is a recently created infographic that gathers, in one place, an array of data points that demonstrate the remarkable magnitude of the EpicLeap program.

By Vanderbilt Health News
January 19, 2017

Study to track diabetes drug’s ability to also treat asthma

Investigators in the Division of Allergy, Pulmonary, and Critical Care Medicine and the Division of Diabetes, Endocrinology, and Metabolism recently received a $1.25 million grant from the National Institute of Allergy and Infectious Diseases.

By Vanderbilt Health News
Hand holding a small vaccine vial labeled “1 DOSE VIAL 0.5 mL,” “Quadrivalent Human Papillomavirus Types 6, 11, 16, 18,” “Recombinant Vaccine,” and “GARDASIL,” with a lot number and expiration details visible but too small to read.
January 17, 2017

Vanderbilt-Ingram Cancer Center supports national HPV vaccination efforts

Nearly 39,000 new cancers associated with the human papillomavirus (HPV) will be diagnosed in the United States this year. Although HPV vaccines can prevent the majority of these cancers, vaccination rates remain low across the country.

By Vanderbilt Health News